Famotidine
Brand name: Famotidine
Rank #183 of 500 drugs by total cost
$84.3M
Total Cost
5,257,365
Total Claims
$84.3M
Total Cost
91,359
Prescribers
$16
Cost per Claim
1,394,949
Beneficiaries
10,024,157
30-Day Fills
$923
Avg Cost/Provider
58
Avg Claims/Provider
About Famotidine
Famotidine (sold as Famotidine) was prescribed 5,257,365 times by 91,359 Medicare Part D providers in 2023, costing the program $84.3M. At $16 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 180 | Galcanezumab-Gnlm (Emgality Pen) | $87.0M | 101,221 |
| 181 | Imatinib Mesylate (Imatinib Mesylate) | $85.0M | 40,908 |
| 182 | Clopidogrel Bisulfate (Clopidogrel) | $84.7M | 5,428,304 |
| 183 | Famotidine (Famotidine) | $84.3M | 5,257,365 |
| 184 | Mifepristone (Korlym) | $83.3M | 2,397 |
| 185 | Insulin Nph Hum/Reg Insulin Hm (Humulin 70-30) | $82.3M | 177,501 |
| 186 | Montelukast Sodium (Montelukast Sodium) | $81.3M | 5,086,706 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology